blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3698631

EP3698631 - METHODS OF DELIVERING OLIGONUCLEOTIDES TO IMMUNE CELLS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.07.2024
Database last updated on 21.01.2025
FormerExamination is in progress
Status updated on  27.01.2023
FormerRequest for examination was made
Status updated on  03.09.2021
FormerThe application has been published
Status updated on  24.07.2020
Most recent event   Tooltip12.07.2024Application deemed to be withdrawnpublished on 14.08.2024  [2024/33]
Applicant(s)For all designated states
Arbutus Biopharma Corporation
100- 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8 / CA
[2020/35]
Inventor(s)01 / NOVOBRANTSEVA, Tatiana
ALNYLAM PHARMACEUTICALS INC.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
02 / AKINC, Akin
ALNYLAM PHARMACEUTICALS INC.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
03 / SUGO, Tsukasa
ALNYLAM PHARMACEUTICALS INC.
300 Third Street
Cambridge, MA Massachusetts 02142 / US
 [2020/35]
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[2020/35]
Application number, filing date20150010.505.05.2010
[2020/35]
Priority number, dateUS200917577709P05.05.2009         Original published format: US 17577709 P
US200923404509P14.08.2009         Original published format: US 23404509 P
US200924276109P15.09.2009         Original published format: US 24276109 P
US200925199109P15.10.2009         Original published format: US 25199109 P
US200925884809P06.11.2009         Original published format: US 25884809 P
[2020/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP3698631
Date:26.08.2020
Language:EN
[2020/35]
Type: A3 Search report 
No.:EP3698631
Date:25.11.2020
Language:EN
[2020/48]
Search report(s)(Supplementary) European search report - dispatched on:EP22.10.2020
ClassificationIPC:A01N43/04, A61K31/70, A61K9/127, A61K31/713, A61K47/69, A61P19/02, A61P43/00, A61P37/02, A61P29/00
[2020/35]
CPC:
A61K31/713 (EP,US); A61K47/6911 (EP,US); A61K9/127 (EP,US);
A61K9/1277 (EP,US); A61P19/02 (EP); A61P29/00 (EP);
A61P37/02 (EP); A61P43/00 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2021/40]
Former [2020/35]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERFAHREN ZUR ABGABE VON OLIGONUKLEOTIDEN AN IMMUNZELLEN[2020/35]
English:METHODS OF DELIVERING OLIGONUCLEOTIDES TO IMMUNE CELLS[2020/35]
French:PROCÉDÉS D'ADMINISTRATION D'OLIGONUCLÉOTIDES DANS DES CELLULES IMMUNES[2020/35]
Examination procedure26.08.2021Amendment by applicant (claims and/or description)
26.08.2021Examination requested  [2021/40]
26.08.2021Date on which the examining division has become responsible
31.01.2023Despatch of a communication from the examining division (Time limit: M06)
11.08.2023Application deemed to be withdrawn, date of legal effect  [2024/33]
01.09.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/33]
Parent application(s)   TooltipEP10772775.2  / EP2416652
EP18203606.1  / EP3504967
Request for further processing for:The application is deemed to be withdrawn due to non-payment of the examination fee
26.08.2021Request for further processing filed
26.08.2021Full payment received (date of receipt of payment)
Request granted
13.09.2021Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
26.08.2021Request for further processing filed
26.08.2021Full payment received (date of receipt of payment)
Request granted
13.09.2021Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
TR, SM, SK, SI, SE, RO, PT, PL, NO, NL, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL
26.08.2021Request for further processing filed
26.08.2021Full payment received (date of receipt of payment)
Request granted
13.09.2021Decision despatched
Fees paidRenewal fee
09.01.2020Renewal fee patent year 03
09.01.2020Renewal fee patent year 04
09.01.2020Renewal fee patent year 05
09.01.2020Renewal fee patent year 06
09.01.2020Renewal fee patent year 07
09.01.2020Renewal fee patent year 08
09.01.2020Renewal fee patent year 09
09.01.2020Renewal fee patent year 10
14.05.2020Renewal fee patent year 11
12.05.2021Renewal fee patent year 12
28.03.2022Renewal fee patent year 13
12.04.2023Renewal fee patent year 14
27.05.2024Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO03106636  (MIRUS CORP [US]) [Y] 1-13 * the whole document * * example -; claim - *;
 [E]WO2010053572  (MASSACHUSETTS INST TECHNOLOGY [US], et al) [E] 1-13 * the whole document * * paragraphs [0288] - [0291]; example -; claim -; compounds C12-200 * * examples 7,14 *;
 [Y]  - AKINC AKIN ET AL, "A combinatorial library of lipid-like materials for delivery of RNAi therapeutics", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 26, no. 5, doi:10.1038/NBT1402, ISSN 1087-0156, (20080501), pages 561 - 569, (20080427), XP002527175 [Y] 1-13 * the whole document * * Supplementary material;; figure 1 *

DOI:   http://dx.doi.org/10.1038/nbt1402
 [Y]  - HONG K ET AL, "Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, (19970103), vol. 400, no. 2, doi:10.1016/S0014-5793(96)01397-X, ISSN 0014-5793, pages 233 - 237, XP004262049 [Y] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0014-5793(96)01397-X
 [T]  - MUTHUSAMY JAYARAMAN ET AL, "Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, (20120820), vol. 51, no. 34, doi:10.1002/anie.201203263, ISSN 1433-7851, pages 8529 - 8533, XP055063645 [T] 1-13

DOI:   http://dx.doi.org/10.1002/anie.201203263
 [T]  - DAVID N. NGUYEN ET AL, "Drug Delivery-mediated Control of RNA Immunostimulation", MOLECULAR THERAPY, (20090707), vol. 17, no. 9, doi:10.1038/mt.2009.147, ISSN 1525-0016, pages 1555 - 1562, XP055063671 [T] 1-13

DOI:   http://dx.doi.org/10.1038/mt.2009.147
 [T]  - LIU YANG ET AL, "Designer Lipids Advance Systemic siRNA Delivery", MOLECULAR THERAPY : THE JOURNAL OF THE AMERICAN SOCIETY OF GENE THERAPY, CELL PRESS, US, (20100401), vol. 18, no. 4, doi:10.1038/MT.2010.39, ISSN 1525-0016, pages 669 - 670, XP002684383 [T] 1-13 * figure 1 * * the whole document *

DOI:   http://dx.doi.org/10.1038/MT.2010.39
by applicantUS3687808
 US3993754
 US4145410
 US4224179
 US4235871
 US4469863
 US4476301
 US4522803
 US4588578
 US4603044
 US4737323
 US4845205
 EP0360257
 US4927637
 US4957773
 US4981957
 US4987071
 WO9103162
 US5008050
 US5013556
 US5023243
 US5032401
 US5034506
 WO9207065
 US5118800
 US5130302
 US5134066
 US5166315
 US5175273
 US5177196
 US5185444
 US5188897
 US5214134
 US5216141
 WO9315187
 US5235033
 US5264423
 US5264562
 US5264564
 WO9323569
 US5276019
 US5278302
 WO9402595
 US5286634
 US5286717
 US5319080
 US5321131
 WO9413688
 US5334711
 US5359044
 US5367066
 US5393878
 US5399676
 US5405939
 US5405938
 US5432272
 US5434257
 US5446137
 US5453496
 US5455233
 US5457187
 US5459255
 US5466677
 US5466786
 US5470967
 US5476925
 US5484908
 US5489677
 US5502177
 US5514785
 US5519126
 US5519134
 US5525711
 US5534499
 US5536821
 US5539082
 US5541306
 US5541307
 US5550111
 US5552540
 US5561225
 US5563253
 US5567811
 US5571799
 US5576427
 US5587361
 US5587469
 US5591317
 US5591722
 US5594121
 US5596086
 US5596091
 US5597909
 US5602240
 US5608046
 US5607677
 US5610288
 US5610289
 US5610300
 US5614617
 US5618704
 US5623070
 US5625050
 US5627053
 US5631359
 US5633360
 US5639873
 US5646265
 US5658873
 US5663312
 US5670633
 US5677437
 US5677439
 US5681941
 US5700920
 US5714331
 US5718709
 US5719262
 US5739119
 US5747470
 US5759829
 US5783683
 US5789573
 US5801154
 US5820873
 US5885613
 US6027726
 WO0115726
 US6320017
 US6406705
 WO02069369
 US6534018
 US6855277
 US2005281781
 US2006240093
 US2007042031
 US2007135372
 WO2008042973
    - Biochim Biophys Acta, (19791019), vol. 557, no. 1, pages 9 - 23
    - Biochim Biophys Acta, (19801002), vol. 601, no. 3, pages 559 - 7
    - Biochim Biophys Acta, (19860613), vol. 858, no. 1, pages 161 - 8
    - Biochim. Biophys. Acta, (19850000), vol. 812, pages 55 - 65
    - Pharmaceuticals Research, (20050300), vol. 22, no. 3, pages 362 - 372
    - LOVE et al., "Lipid-like materials for low-dose, in vivo gene silencing", Proc Natl Acad Sci USA., (20100000), vol. 107, doi:10.1073/pnas.0910603106, pages 1864 - 9, XP055077922

DOI:   http://dx.doi.org/10.1073/pnas.0910603106
    - KUNKEL et al., Brit. Med Bull., (19890000), vol. 45, no. 3, pages 630 - 643
    - GOODFELLOW, Nature, (19890000), vol. 341, pages 102 - 103
    - BENNETT et al., Mol. Pharm., (19920000), vol. 41, pages 1023 - 1033
    - ZHU et al., Science, (19930000), vol. 261, pages 209 - 211
    - HYDE et al., Nature, (19930000), vol. 362, pages 250 - 256
    - BRIGHAM et al., Am. J. Med. Sci., (19890000), vol. 298, pages 278 - 281
    - STRAUBRINGER et al., METHODS IN ENZYMOLOGY, Academic Press, (19830000), vol. 101, pages 512 - 527
    - MANNINO et al., Biotechniques, (19880000), vol. 6, pages 682 - 690
    - NICOLAU et al., Crit. Rev. Ther. Drug Carrier Syst., (19890000), vol. 6, pages 239 - 271
    - BEHR, Acc. Chem. Res., (19930000), vol. 26, pages 274 - 278
    - BRIGHAM et al., Am. J. Sci., (19890000), vol. 298, no. 4, pages 278 - 281
    - ZALIPSKY, FEBS Letters, (19940000), vol. 353, pages 71 - 74
    - "Covalent Attachment of Proteins to Liposomes", HEATH, The Merck Manual of Diagnosis and Therapy, Academic Press, Inc, (19870000), vol. 149, pages 2499 - 2506,46-49
    - FOUGEROLLES, A. et al., Nature Reviews, (20070000), vol. 6, pages 443 - 453
    - LAMBERTON, J.S.CHRISTIAN, A.T., Molecular Biotechnology, (20030000), vol. 24, pages 111 - 119
    - ELSHABIR, S.M. et al., Nature, (20010000), vol. 411, pages 494 - 498
    - CAPLEN, N. et al., Proc. Natl. Acad. Sci. USA, (20010000), vol. 98, pages 9746 - 9747
    - BROWN, D. et al., TechNotes, vol. 9, no. 1, (20020901), pages 1 - 7, URL: ambion.com/techlib/tn/91/912.html
    - ELSHABIR, S.M. et al., EMBO, (20010000), vol. 20, pages 6877 - 6888
    - ELSHABIR, S. et al., EMBO J., (20010000), vol. 20, pages 6877 - 6888
    - PADDISON, P. et al., Genes Dev., (20020000), vol. 16, no. 8, pages 948 - 58
    - PADDISON, P. et al., Proc. Natl. Acad. Sci. USA, (20020000), vol. 99, no. 3, pages 1443 - 1448
    - PADDISON et al., Genes & Dev., (20020000), vol. 16, no. 8, pages 948 - 58
    - GRIFFITHS-JONES SGROCOCK RJVAN DONGEN SBATEMAN AENRIGHT AJ, "miRBase: microRNA sequences, targets and gene nomenclature", NAR, (20060000), vol. 34, pages D140 - D144
    - GRIFFITHS-JONES S, "The microRNA Registry", NAR, (20040000), vol. 32, pages D109 - D1 11
    - JASKULSKI et al., Science, (19880610), vol. 240, no. 4858, pages 1544 - 6
    - VASANTHAKUMARAHMED, Cancer Commun., (19890000), vol. 1, no. 4, pages 225 - 32
    - PERIS et al., Brain Res Mol Brain Res., (19980615), vol. 57, no. 2, pages 310 - 20
    - ALTSCHUL et al., Nucleic Acids Res., (19970000), vol. 25, no. 17, pages 3389 - 402
    - KIMCECH, Proc Natl Acad Sci U S A., (19871200), vol. 84, no. 24, pages 8788 - 92
    - FORSTERSYMONS, Cell, (19870424), vol. 49, no. 2, pages 211 - 20
    - CECH et al., Cell, (19811200), vol. 27, no. 3, pages 487 - 96
    - MICHELWESTHOF, J Mol Biol., (19901205), vol. 216, no. 3, pages 585 - 610
    - REINHOLD-HUREKSHUB, Nature, (19920514), vol. 357, no. 6374, pages 173 - 6
    - ROSSI et al., Nucleic Acids Res., (19920911), vol. 20, no. 17, pages 4559 - 65
    - HAMPELTRITZ, Biochemistry, (19890613), vol. 28, no. 12, pages 4929 - 33
    - HAMPEL et al., Nucleic Acids Res., (19900125), vol. 18, no. 2, pages 299 - 304
    - PERROTTABEEN, Biochemistry, (19921201), vol. 31, no. 47, pages 11843 - 52
    - GUERRIER-TAKADA et al., Cell, (19831200), vol. 35, no. 3, pages 849 - 57
    - SAVILLECOLLINS, Cell, (19900518), vol. 61, no. 4, pages 685 - 96
    - SAVILLECOLLINS, Proc Natl Acad Sci USA., (19911001), vol. 88, no. 19, pages 8826 - 30
    - COLLINSOLIVE, Biochemistry, (19930323), vol. 32, no. 11, pages 2795 - 9
    - RANEY et al., Journal of Pharmacology and Experimental Therapeutics, (20010000), vol. 298, pages 1185 - 1192
    - KURRECK, J., "Antisense technologies. Improvement through novel chemical modifications", Eur J Biochem, (20030000), vol. 270, doi:10.1046/j.1432-1033.2003.03555.x, pages 1628 - 44, XP009045309

DOI:   http://dx.doi.org/10.1046/j.1432-1033.2003.03555.x
    - KURRECK, Eur. J. Biochem., (20030000), vol. 270, pages 1628 - 44
    - HALL et al., Nucleic Acids Res., (20040000), vol. 32, pages 5991 - 6000
    - ZHANG et al., Curr. Top. Med. Chem., (20060000), vol. 6, pages 893 - 900
    - BLUME et al., Biochimica et Biophysica Acta, (19930000), vol. 1149, pages 180 - 184
    - MANOHARAN, Curr. Opin. Chem. Biol., (20040000), vol. 8, pages 570 - 9
    - HOLEN, Nucleic Acids Res., (20030000), vol. 31, pages 2401 - 7
    - PRAKASH et al., J. Med. Chem, (20050000), vol. 48, pages 4247 - 53
    - MARTIN et al., Helv. Chim. Acta, (19950000), vol. 78, pages 486 - 504
    - NIELSEN et al., Science, (19910000), vol. 254, pages 1497 - 1500
    - FEIGNER, Scientific American
    - SAPRA, P.ALLEN, TM, Prog. Lipid Res., (20030000), vol. 42, no. 5, pages 439 - 62
    - ABRA, RM et al., J. Liposome Res., (20020000), vol. 12, pages 1 - 3
    - ALLEN, Biochimica et Biophysica Acta, (19950000), vol. 1237, pages 99 - 108
    - DEFREES et al., Journal of the American Chemistry Society, (19960000), vol. 118, pages 6101 - 6104
    - KLIBANOV et al., Journal of Liposome Research, (19920000), vol. 2, pages 321 - 334
    - ZALIPSKY, Bioconjugate Chemistry, (19930000), vol. 4, pages 296 - 299
    - KIRPOTIN et al., FEBS Letters, (19960000), vol. 388, pages 115 - 118
    - RENNEISEN et al., J. Bio. Chem., (19900000), vol. 265, pages 16337 - 16342
    - LEONETTI et al., Proc. Natt. Acad. Sci. (USA), (19900000), vol. 87, pages 2448 - 2451
 US19430603793
 US20150092565
 CN19921010298
 US19950486214
 US19970886829
 US19980093152
 US19980108673
 US19990315298
 US20080045228
 US20090156851
 US20090171439
 US20090175770
 US20090185800
 US20090225898
 WO2009US63933
 WO2009US63931
 WO2009US63927
 US20100299291
 WO2010US22614
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.